Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese
- PMID: 21886581
- PMCID: PMC3137171
- DOI: 10.2174/157015911795017119
Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese
Abstract
Endothelial nitric oxide synthase (NOS3) is one of the enzymes influencing nitric oxide (NO) function in the human brain. NO is a gaseous neurotransmitter that is involved in a variety of mechanisms in the central nervous system, such as N-methyl-D-aspartate receptor activation and oxidative stress. The evidence from animal pharmacological studies and postmortem studies supports an association between NO and psychotic disorders. Methamphetamine (METH) use disorder is a known psychotic disorder, and we therefore conducted a gene-based case-control study between tagging single nucleotide polymorphisms (SNPs) (rs2070744, rs1799983) in NOS3 and METH-induced psychosis in Japanese subjects (183 with METH-induced psychosis and 267 controls). Written informed consent was obtained from each subject. No significant association was found between any tagging SNP in NOS3 and METH-induced psychosis in the allele/genotype-wise or haplotype-wise analyses. In conclusion, we suggest that NOS3 might not contribute to the risk of METH-induced psychosis in the Japanese population.
Keywords: Methamphetamine-induced psychosis; endothelial nitric oxide synthase (NOS3); gene-based case-control association study..
Similar articles
-
Genetic Association Analysis of NOS1 and Methamphetamine-Induced Psychosis Among Japanese.Curr Neuropharmacol. 2011 Mar;9(1):155-9. doi: 10.2174/157015911795017308. Curr Neuropharmacol. 2011. PMID: 21886582 Free PMC article.
-
Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients.Neuropharmacology. 2010 Feb;58(2):452-6. doi: 10.1016/j.neuropharm.2009.09.006. Epub 2009 Sep 10. Neuropharmacology. 2010. PMID: 19747927
-
Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population.Drug Alcohol Depend. 2011 Jan 1;113(1):1-7. doi: 10.1016/j.drugalcdep.2010.06.021. Epub 2010 Aug 11. Drug Alcohol Depend. 2011. PMID: 20705401
-
Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases.Nitric Oxide. 2017 Feb 28;63:39-51. doi: 10.1016/j.niox.2016.08.004. Epub 2016 Aug 25. Nitric Oxide. 2017. PMID: 27569446 Review.
-
Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms.Gene. 2016 Jan 10;575(2 Pt 3):584-99. doi: 10.1016/j.gene.2015.09.061. Epub 2015 Sep 28. Gene. 2016. PMID: 26428312 Free PMC article. Review.
Cited by
-
Molecular profiling of reticular gigantocellularis neurons indicates that eNOS modulates environmentally dependent levels of arousal.Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6900-E6909. doi: 10.1073/pnas.1806123115. Epub 2018 Jul 2. Proc Natl Acad Sci U S A. 2018. PMID: 29967172 Free PMC article.
-
Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.Neurosci Biobehav Rev. 2021 Jan;120:48-74. doi: 10.1016/j.neubiorev.2020.11.001. Epub 2020 Nov 17. Neurosci Biobehav Rev. 2021. PMID: 33217458 Free PMC article.
-
IL-10 (-819C/T), TNFA (-30G/A) and ENOS (-786T/C) Polymorphisms Modulating the Outcome Related to Mental Disorders in Crack Addicted Users.Clin Pract Epidemiol Ment Health. 2022 Feb 8;18:e174501792201140. doi: 10.2174/17450179-v18-e2201140. eCollection 2022. Clin Pract Epidemiol Ment Health. 2022. PMID: 37274848 Free PMC article.
-
Genetic Factors of Nitric Oxide's System in Psychoneurologic Disorders.Int J Mol Sci. 2020 Feb 26;21(5):1604. doi: 10.3390/ijms21051604. Int J Mol Sci. 2020. PMID: 32111088 Free PMC article. Review.
References
-
- Munzar P, Tanda G, Justinova Z, Goldberg SR. Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology. 2004;29:705–717. - PubMed
-
- Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: the state of the science. Am. J. Psychiatry. 2005;162:1432–1440. - PubMed
-
- Anderson KL, Itzhak Y. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse. Ann. N.Y. Acad. Sci. 2006;1074:225–233. - PubMed
-
- Snyder SH, Ferris CD. Novel neurotransmitters and their neuropsychiatric relevance. Am. J. Psychiatry. 2000;157:1738–1751. - PubMed
-
- Yao JK, Reddy RD. Metabolic investigation in psychiatric disorders. Mol. Neurobiol. 2005;31:193–203. - PubMed
LinkOut - more resources
Full Text Sources